Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of PI-88 in Patients With Advanced Melanoma

This study has been completed.
Information provided by:
Medigen Biotechnology Corporation Identifier:
First received: September 9, 2003
Last updated: March 30, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)